HealthEquity Price to Sales Ratio 2014-2025 | HQY
Historical PS ratio values for HealthEquity (HQY) over the last 10 years. The current P/S ratio for HealthEquity as of May 28, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| HealthEquity P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-05-28 | 101.48 | 7.50 | |
| 2025-01-31 | 110.42 | $13.54 | 8.16 |
| 2024-10-31 | 85.25 | $13.05 | 6.53 |
| 2024-07-31 | 78.48 | $12.52 | 6.27 |
| 2024-04-30 | 78.91 | $11.95 | 6.60 |
| 2024-01-31 | 75.58 | $11.54 | 6.55 |
| 2023-10-31 | 71.68 | $11.29 | 6.35 |
| 2023-07-31 | 67.94 | $10.98 | 6.19 |
| 2023-04-30 | 53.45 | $10.60 | 5.04 |
| 2023-01-31 | 60.85 | $10.21 | 5.96 |
| 2022-10-31 | 77.91 | $9.89 | 7.88 |
| 2022-07-31 | 58.17 | $9.49 | 6.13 |
| 2022-04-30 | 62.32 | $9.31 | 6.69 |
| 2022-01-31 | 53.44 | $9.12 | 5.86 |
| 2021-10-31 | 66.18 | $9.16 | 7.23 |
| 2021-07-31 | 73.98 | $9.31 | 7.95 |
| 2021-04-30 | 75.97 | $9.48 | 8.02 |
| 2021-01-31 | 83.55 | $9.85 | 8.48 |
| 2020-10-31 | 51.49 | $10.30 | 5.00 |
| 2020-07-31 | 51.56 | $10.23 | 5.04 |
| 2020-04-30 | 56.27 | $9.12 | 6.17 |
| 2020-01-31 | 66.06 | $7.85 | 8.42 |
| 2019-10-31 | 56.79 | $6.11 | 9.30 |
| 2019-07-31 | 81.98 | $4.98 | 16.46 |
| 2019-04-30 | 67.75 | $4.78 | 14.17 |
| 2019-01-31 | 62.34 | $4.53 | 13.75 |
| 2018-10-31 | 91.80 | $4.32 | 21.27 |
| 2018-07-31 | 75.50 | $4.13 | 18.28 |
| 2018-04-30 | 65.67 | $3.93 | 16.71 |
| 2018-01-31 | 50.62 | $3.72 | 13.61 |
| 2017-10-31 | 50.22 | $3.52 | 14.25 |
| 2017-07-31 | 45.87 | $3.33 | 13.79 |
| 2017-04-30 | 45.52 | $3.15 | 14.47 |
| 2017-01-31 | 46.25 | $2.99 | 15.49 |
| 2016-10-31 | 33.23 | $2.81 | 11.81 |
| 2016-07-31 | 29.52 | $2.61 | 11.32 |
| 2016-04-30 | 25.15 | $2.38 | 10.55 |
| 2016-01-31 | 21.55 | $2.16 | 9.98 |
| 2015-10-31 | 32.71 | $2.03 | 16.12 |
| 2015-07-31 | 33.66 | $1.89 | 17.78 |
| 2015-04-30 | 26.21 | $1.88 | 13.96 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $8.748B | $1.200B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $135.390B | 25.39 |
| Elevance Health (ELV) | United States | $84.947B | 10.96 |
| CVS Health (CVS) | United States | $77.596B | 9.64 |
| Cencora (COR) | United States | $56.866B | 19.78 |
| DiDi Global (DIDIY) | China | $22.921B | 34.79 |
| Natera (NTRA) | United States | $21.460B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.549B | 13.28 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.465B | 0.00 |
| CochLear (CHEOY) | Australia | $11.562B | 0.00 |
| Revvity (RVTY) | United States | $10.871B | 18.71 |
| ICON (ICLR) | Ireland | $10.610B | 9.86 |
| Viatris (VTRS) | United States | $10.094B | 3.47 |
| Doximity (DOCS) | United States | $9.727B | 45.30 |
| Avantor (AVTR) | United States | $8.961B | 13.02 |
| Medpace Holdings (MEDP) | United States | $8.582B | 22.79 |
| Sonic Healthcare (SKHHY) | Australia | $8.220B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.810B | 13.35 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 27.18 |
| Bausch + Lomb (BLCO) | Canada | $4.171B | 24.58 |
| BrightSpring Health Services (BTSG) | United States | $4.074B | 37.71 |
| Sotera Health (SHC) | United States | $3.528B | 20.05 |
| Surgery Partners (SGRY) | United States | $2.954B | 38.42 |
| Alignment Healthcare (ALHC) | United States | $2.920B | 0.00 |
| Concentras Parent (CON) | United States | $2.761B | 15.96 |
| Organon (OGN) | United States | $2.376B | 2.52 |
| Ardent Health Partners (ARDT) | United States | $2.127B | 9.07 |
| GeneDx Holdings (WGS) | United States | $1.997B | 76.91 |
| Premier (PINC) | United States | $1.896B | 14.39 |
| Progyny (PGNY) | United States | $1.765B | 38.85 |
| PACS (PACS) | United States | $1.558B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.368B | 27.36 |
| Teladoc Health (TDOC) | United States | $1.242B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.190B | 9.05 |
| Establishment Labs Holdings (ESTA) | $1.067B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.982B | 15.33 |
| Agilon Health (AGL) | United States | $0.923B | 0.00 |
| Nutex Health (NUTX) | United States | $0.911B | 13.77 |
| AMN Healthcare Services Inc (AMN) | United States | $0.822B | 7.70 |
| QDM (QDMI) | Hong Kong, SAR China | $0.743B | 0.00 |
| Embecta (EMBC) | United States | $0.658B | 4.43 |
| InnovAge Holding (INNV) | United States | $0.545B | 0.00 |
| Enhabit (EHAB) | United States | $0.529B | 43.54 |
| LifeMD (LFMD) | United States | $0.524B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.484B | 10.90 |
| SBC Medicals (SBC) | United States | $0.477B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.471B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.400B | 0.00 |
| Oncology Institute (TOI) | United States | $0.269B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.220B | 0.00 |
| Beauty Health (SKIN) | United States | $0.213B | 0.00 |
| KindlyMD (NAKA) | United States | $0.151B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.142B | 23.17 |
| OncoCyte (OCX) | United States | $0.093B | 0.00 |
| So-Young (SY) | China | $0.090B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.063B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Biodesix (BDSX) | United States | $0.051B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.020B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |